elegantpie Free

Comics I Follow

Clay Jones

Recent Comments

3 days ago on Michael Ramirez

U.S. Producers Break Annual Oil Production Record – Forbes Dec 2023
4 days ago on Michael Ramirez

U.S. Producers Break Annual Oil Production Record – Forbes Dec 2023
4 days ago on Michael Ramirez

U.S. Producers Break Annual Oil Production Record – Forbes Dec 2023
6 months ago on Mike Lester

Ha ha. As if the right loves queers.
8 months ago on Bob Gorrell

The very REASON for the impeachment inquiry is to get more power to FIND the evidence, if any. If they already had the evidence, they would not need the inquiry.
9 months ago on Mike Lester

New England Journal of Medicine
Original ArticleVOL. 387 No. 7, Aug 18, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease.
Google this number:
NEJMoa2201662
aaabbbcccdddeeefff
New England Journal of Medicine
Original ArticleVOL. 386 No. 18, May 05, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19
In this double-blind, randomized, placebo-controlled trial, ivermectin that was administered within 7 days after Covid-19 symptom onset was shown not to be of any clinical benefit.
Google this number:
NEJMoa2115869
9 months ago on Mike Lester

New England Jopurnal of Medicine
Original ArticleVOL. 387 No. 7, Aug 18, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease.
Google this number:
NEJMoa2201662
New England Jopurnal of Medicine
Original ArticleVOL. 386 No. 18, May 05, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19
In this double-blind, randomized, placebo-controlled trial, ivermectin that was administered within 7 days after Covid-19 symptom onset was shown not to be of any clinical benefit.
Google this number:
NEJMoa2115869
9 months ago on Mike Lester

New England Jopurnal of Medicine
Original ArticleVOL. 387 No. 7, Aug 18, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease.
Google this number:
NEJMoa2201662
9 months ago on Mike Lester

New England Jopurnal of Medicine
Original ArticleVOL. 386 No. 18, May 05, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19
In this double-blind, randomized, placebo-controlled trial, ivermectin that was administered within 7 days after Covid-19 symptom onset was shown not to be of any clinical benefit.
Google this number:
NEJMoa2115869
9 months ago on Mike Lester

In August 2023, the U.S. Food and Drug Administration reversed course and admitted that doctors would be allowed to prescribe ivermectin for treatment of COVID-19.
FALSE.
The FDA has never asserted that the off-label prescribing of ivermectin for COVID-19 was prohibited; the agency has reiterated this point in court and in public filings many times prior to August 2023.
Several flaws existed with these assertions. First, the FDA has never had the authority to prevent doctors from prescribing FDA-approved drugs like ivermectin for off-label uses. The FDA regulates how manufacturers of drugs can advertise and label their drugs to the public and to doctors, but that authority does not extend to regulating how doctors prescribe these medications.
See story on Snopes